{
	"kja6ikirText": "Brintellix® Pharmacokinet<span class=\"_ _0\"></span>ic Profile<span class=\"_ _3\"></span><span class=\"fs1 ls5 v1\">1</span>",
	"kja6ikisText": "The mean <span class=\"ff1 fc0 ws29\">half-life</span> of <br>Brintellix® is approxima<span class=\"_ _2\"></span>tely <div><span style=\"color: rgb(77, 127, 134); font-family: &quot;1_YNCPSC+AvenirNextLTPro-Bold&quot;;\">66 hours</span><br></div>",
	"kja6ikiuText": "Steady-state plasma<br>concentr<span class=\"_ _2\"></span>ations ar<span class=\"_ _2\"></span>e typically<br>achieved within <span class=\"ff1 fc0\">2 weeks</span> of<br>dosing Brintellix®",
	"kja6ikivText": "The pharmacokinetics of<br>Brintellix® (2.5 mg to 60 mg) ar<span class=\"_ _2\"></span>e<br><span class=\"ff1 fc0 ws29\">linear</span> and <span class=\"ff1 fc0 ws29\">dose-propor<span class=\"_ _2\"></span>tional<br><span class=\"ff3 fc1 wsb\">when administered once daily</span></span>",
	"kja6ikiwText": "The maximal plasma <br>Brintellix® concentr<span class=\"_ _2\"></span>ation <br><span class=\"ws29\">(C<span class=\"fs11 ws2a v7\">max</span></span>) after dosing is r<span class=\"_ _2\"></span>eached <br>within <span class=\"ff1 fc0\">7 to 11 hours</span> post <br>dose (T<span class=\"fs11 ws2a v7\">max</span>)",
	"kja6ikixText": "Absolute bioavailability <br>of Brintellix® is <span class=\"ff1 fc0 ws29\">75%</span>; <br>no effect of<span class=\"_ _0\"></span> food on the <br>pharmacokinetics<br>was observed",
	"kja6ikiyText": "P<span class=\"_ _2\"></span>rescribe<span class=\"_ _14\"> </span>High dose<span class=\"_ _11\"> </span>Pr<span class=\"_ _2\"></span>esentation<span class=\"_ _17\"></span><span class=\"ff1 fc3\">Pharmacokinetic</span>",
	"Brintellix_61108e877d": "<span class=\"ff2 fc0 fs13\">References</span>",
	"Brintellix_615537d900": "<div class=\"ff3 fc1\" style=\"font-size:15px;\"><span class=\"ff2\">1.</span>&nbsp;Brintellix® Summary of Product Characteristics. 2021.</div>"
}
